Pharma Journalist -

The Phase III THEMIS trial met its primary endpoint and demonstrated that Brilinta (ticagrelor), taken in conjunction with aspirin, showed a statistically-significant reduction in a…
Read More...

AbbVie and Voyager Therapeutics announced an exclusive, global strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed at pathological…
Read More...

Mallinckrodt Pharmaceuticals announced it has entered into a research collaboration agreement with Transimmune AG, a company developing novel immunotherapies based on its unique…
Read More...

Titan Pharmaceuticals announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment…
Read More...

In recent years, big health has risen as a national policy of China with the introduction of the “Healthy China 2030” Planning Outline, and China has specified the new positioning of…
Read More...

Animal Health & Feed Zone of CPhI China 2019 to Build a New Benchmark for the Industry Size of the global veterinary drug market continues to grow as the market continues to…
Read More...

As the race for the first FDA-approved microbiome-based therapeutic continues, join the 4th Microbiome Movement – Drug Development Summit this June to hear directly from 5 key industry…
Read More...

Abbott and Novo Nordisk announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital…
Read More...

Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for ESPEROCT for the treatment of adults and children with…
Read More...

Xencor, Inc. announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase 1 study of XmAb14045, a CD123 x CD3 bispecific antibody molecule…
Read More...